The pharmaceutical giant, Pfizer, is using Semafor to brag about its generosity abroad as it hikes U.S. drug prices.
by Andrew Perez, The Lever
Pfizer recently made headlines for hiking prices on roughly 100 drugs in the United States, shortly after the company announced plans to quadruple the price of its COVID-19 vaccine. Now, the pharmaceutical giant is paying news outlets to tell a different story — a fawning tale about how the company has been altruistically working to expand access to its products overseas.
On Tuesday, the news website Semafor ran a sponsored post from Pfizer bragging about the drugmaker’s efforts to “increase access to health care innovation” in low-income countries. Pfizer has also sponsored Semafor’s D.C.-focused “Principals” newsletter for Washington insiders in recent days. Next week, The Hill will host an event sponsored by Pfizer entitled “Expanding Adult Vaccine Access,” which will feature several D.C. lawmakers and a top federal health care regulator.
The Pfizer sponsorships are just the latest examples of how, when the news coverage gets rough, big businesses can pay corporate media to change the narrative and run counter-programming — with the hope that policymakers and consumers will be sufficiently distracted from the stories that really matter.
Recent Posts
The Winner at the DNC’s Latest Meeting? Israel, Ethnic Cleansing and Genocide
Take Action Now A panel named the Middle East Working Group gummed up all efforts to align the DNC with the views of most Democratic voters, even…
Will Youth Prisons Be Found Only in History Books?
Take Action Now At least two-thirds of youth prisons and jails have been shut down. This is an enormous, dramatic, positive development in an era…
Why are Democratic Leaders Still Ignoring Voters on Israel?
Take Action Now Decisions at the latest Democratic National Committee meeting emphasized the disconnect between the party’s leadership and its base……
DNC Chair Ken Martin’s Broken Promises Haunt his Tenure and the Party
Take Action Now Martin ran for chair on a platform that emphasized his commitment to transparency and to getting big money out of Democratic Party…